Detalhe da pesquisa
1.
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial.
Br J Psychiatry
; 223(6): 533-541, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38108319